Protalix BioTherapeutics Inc (AMEX:PLX) concluded the trading at $1.58 on Friday, June 06 with a rise of 3.95% from its closing price on previous day. Company’s P/E ratio for the trailing 12 months is 37.62. Considering stock’s 52-week price range provides that PLX hit a
Protalix BioTherapeutics Inc (AMEX:PLX) shares, rose in value, with the stock price up by 1.92% to the previous day’s close as strong demand from buyers drove the stock to $1.59. Actively observing the price movement in the last trading, the stock closed the session at
Protalix Bio Therapeutics, Inc. (PLX) stock soared 46.67% in the pre-market trading session at the price of $1.54 after reporting topline data from the BALANCE clinical trial evaluating PRX–102. PLX is a biopharmaceutical firm that develops and commercializes therapeutic proteins using its plant cell-based ProCellEx
Stocks Register is a comprehensive online news hub delivering daily updates on various facets of U.S. life, including business, technology, politics, economy, culture, sports, and noteworthy global events.